Novartis | NOVN - Market Capitalization

Stock Price
102.32
Daily Change
-1.66 -1.60%
Monthly
6.56%
Yearly
2.73%
Q3 Forecast
103.29

Novartis reported $208.53B in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change Date
AbbVie USD 327.88B 42.76B Jun/2025
Alcon AG USD 34.72B 6.87B Jun/2025
Almirall EUR 2.29B 195.31M Jun/2025
Amgen USD 150.13B 17.37B Jun/2025
AstraZeneca USD 215.51B 41B Jun/2025
Autolus Therapeutics Ltd 606.8M 194.3M Jun/2025
Bayer EUR 25.09B 3.38B Jun/2025
Biogen USD 18.41B 1.62B Jun/2025
Bristol-Myers Squibb USD 94.2B 29.9B Jun/2025
Eli Lilly USD 738.79B 2.87B Jun/2025
Fresenius EUR 24.04B 1.84B Jun/2025
Fresenius Medical Care EUR 14.27B 870.85M Jun/2025
Galapagos EUR 1.57B 31.54M Jun/2025
Genmab DKK 80.88B 7.82B Jun/2025
Gilead Sciences USD 137.91B 1.77B Jun/2025
GlaxoSmithKline GBP 56.24B 4.11B Jun/2025
GRIFOLS EUR 6.33B 1.14B Jun/2025
Hikma Pharmaceutical USD 4.42B 226.35M Dec/2024
J&J USD 366.71B 32.94B Jun/2025
Merck EUR 47.83B 7.27B Jun/2025
Merck USD 198.77B 27.1B Jun/2025
Novartis USD 256.18B 64.49B Jun/2025
Novartis USD 258.67B 24.42B Sep/2025
Novo Nordisk A/S 1.96T 370.19B Jun/2025
Orion EUR 8.99B 1.28B Jun/2025
Pfizer USD 137.53B 6.19B Jun/2025
Philips EUR 19.65B 2.33B Jun/2025
Recordati EUR 10.98B 42.75M Jun/2025
Regeneron Pharmaceuticals USD 55.87B 13.47B Jun/2025
Sanofi EUR 100.06B 25.78B Jun/2025